Avenda Health
Avenda Health Reports: New Study Demonstrates Avenda Health’s Unfold AI to Better Predict Focal Therapy Success by 77% Percent as Compared to Standard Methods
"These results demonstrate a marked change in how physicians will be able to diagnose and recommend treatment for prostate cancer patients," said Avenda Health CEO Shyam Natarajan, PhD. "By increasing the confidence in which we can predict a tumor's margins, patients and their doctors will have increased certainty that their entire tumor is treated and with the appropriate intervention in correlation to the severity of their case."
Focal Laser Ablation System Receives FDA Approval – Ablates Soft Tissue in a Physician’s Office Requiring No General Anesthesia
Focal laser ablation system uses a proprietary laser needle and a thermal optical sensor to precisely target and treats soft tissue while minimizing the impact on healthy tissues.
